[Quality of life in patients with acute myeloid leukemia].
In oncology, quality of life has become an essential criterion for evaluating the effects of therapy in clinical trials. So far, in adult patients suffering from acute leukemia assessment of quality of life has not been considered possibly due to poor prognosis and the acute course of the disease. Advances in chemotherapy significantly prolong survival of patients with acute myeloid leukemia and may cure a subset of patients. Therefore, the assessment of quality of life of patients undergoing treatment is of growing interest. The following article will discuss the concept and theoretical frame-work of a study designed to evaluate quality of life in adult patients with acute myeloid leukemia undergoing chemotherapy. Preliminary results show the psychooncological relevance of the study for the clinician.